Psychosocial Mobile Application (THRIVE-M) for Patients With Multiple Myeloma

Running, not enrolling · Not applicable

Conditions studied: Multiple Myeloma

In brief

This clinical trial aims to evaluate whether a psychosocial mobile application (THRIVE-M), is efficacious for improving quality of life, psychological distress, and fatigue in patients living with multiple myeloma compared to usual care.

Key facts

Study ID

NCT06073353

Run by

Massachusetts General Hospital

People needed

120

Starts

2023-12-01

Expected to finish

2026-11-01

Last updated by the study team

2026-05-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients (aged 18 years or older) with one of the following diagnoses:
• newly diagnosed multiple myeloma receiving first-line therapy,
• multiple myeloma on maintenance therapy, or
• relapsed multiple myeloma receiving 2nd or 3rd line therapy
• Ability to comprehend, read, and respond to questions in English

You may not qualify if…

• Patients with acute or unstable psychiatric or cognitive conditions that the treating clinicians believe prohibit informed consent or compliance with study procedures

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.